About Glaucoma
The Burden of Glaucoma
Cataract Surgery in Patients with Glaucoma and OHT
Unmet Need
BIM-IOL System
The SpyGlass BIM-IOL System
No Specialized Training Required
Clinical Results to Date
Market Opportunity
Study Data
Preclinical Study
First-in-Human Clinical Trial
Phase 1/2 Clinical Trial
Phase 3 Clinical Trials
Expert Insights
pipeline
About Us
Story
Mission, Vision, Guiding Principles
Our Team
About Glaucoma
The Burden of Glaucoma
Cataract Surgery in Patients with Glaucoma and OHT
Unmet Need
BIM-IOL System
The SpyGlass BIM-IOL System
No Specialized Training Required
Clinical Results to Date
Market Opportunity
Study Data
Preclinical Study
First-in-Human Clinical Trial
Phase 1/2 Clinical Trial
Phase 3 Clinical Trials
Expert Insights
pipeline
About Us
Story
Mission, Vision, Guiding Principles
Our Team
Site Map
ABOUT GLAUCOMA
The Burden of Glaucoma
Cataract Surgery in Patients with Glaucoma and OHT
Unmet Need
BIM-IOL SYSTEM
The SpyGlass BIM-IOL System
No Specialized Training Required
Clinical Results to Date
MARKET OPPORTUNITY
STUDY DATA
Preclinical Study
First-in-Human Clinical Trial
Phase 1/2 Clinical Trial
Phase 3 Clinical Trials
Expert Insights
PIPELINE
ABOUT US
Story
Mission, Vision, Guiding Principles
Our Team
OTHER LINKS
CONNECT WITH US
COOKIE POLICY
CAREERS
CONTACT US
PRIVACY POLICY
TERMS & CONDITIONS
About Glaucoma
The Burden of Glaucoma
Cataract Surgery in Patients with Glaucoma and OHT
Unmet Need
BIM-IOL System
The SpyGlass BIM-IOL System
No Specialized Training Required
Clinical Results to Date
Market Opportunity
Study Data
Preclinical Study
First-in-Human Clinical Trial
Phase 1/2 Clinical Trial
Phase 3 Clinical Trials
Expert Insights
pipeline
About Us
Story
Mission, Vision, Guiding Principles
Our Team
Connect With Us
Cookie Policy
Careers
Contact us
Privacy Policy
Terms & conditions
Please confirm you wish to leave
SpyGlassPharma.com
CONFIRM
CANCEL
Please confirm you wish to open the SpyGlass LinkedIn page in another window.
CONFIRM
CANCEL
Skip to content
